Denmark's STipe Therapeutics raises $22 million in fresh financing

09/30/2019 8:44:00 PM (GMT)

Danish biotechnology company STipe Therapeutics has received 20 million euros ($22 million) in its Series A financing.

Novo Seeds, the early-stage investment arm of Novo Holdings, and Arix Bioscience plc conducted the new funding round.

Furthermore, Wellington Partners Life Science Venture Capital Management GmbH and Sunstone LSV General Partner IV ApS also joined the financing.

STipe Therapeutics intends to use the net proceeds from the latest financing to further develop its therapies.

STipe Therapeutics

All success stories are prepared by Investsize editors which is selecting elite and remarkable information from press releases and anonymous news sources.There is no charge applied for any success stories which is published . Those published success stories are not investment advices and doesnt offer recommendations Alternate Text